Calcium channel blockers function via a specific pharmacological mechanism that inhibits L-type calcium channels on vascular smooth and cardiac muscle cells to regulate intracellular ion influx. By blocking the transmembrane flow of calcium ions required for excitation-contraction coupling, these agents induce vasodilation in arteries and peripheral arterioles while modulating myocardial contractility (negative inotropic), heart rate (negative chronotropic), and AV nodal conduction velocity (negative dromotropic). This theory resides within the domain of cardiovascular pharmacology as a rule governing hemodynamic regulation through selective blockade of voltage-gated calcium channels to manage conditions such as hypertension, angina pectoris, and tachyarrhythmias.
Calcium channel blockers function via a specific pharmacological mechanism that inhibits L-type calcium channels on vascular smooth and cardiac muscle cells to regulate intracellular ion influx. By b…